Evidence map›Paper›PMID 35911971›Full record

ArticleFrontiers in molecular biosciences2022

Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells.

Leisan Bulatova, Daria Savenkova, Alsina Nurgalieva, Daria Reshetnikova, Arina Timonina, Vera Skripova, Mikhail Bogdanov, Ramziya Kiyamova

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Leisan BulatovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Daria SavenkovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Alsina NurgalievaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Daria ReshetnikovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Arina TimoninaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Vera SkripovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Mikhail BogdanovResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Ramziya KiyamovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Kazan Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NaPi2b is a sodium-dependent phosphate transporter that belongs to the SLC34 family of transporters which is mainly responsible for phosphate homeostasis in humans. Although NaPi2b is widely expressed in normal tissues, its overexpression has been demonstrated in ovarian, lung, and other cancers. A valuable set of antibodies, including L2 (20/3) and MX35, and its humanized versions react strongly with an antigen on the surface of ovarian and other carcinoma cells. Although the topology of NaPi2b was predicted

Indexed as

ECDmonoclonal antibodyMX35 antigenNaPi2bovarian cancerSLC34A2topology

Identifiers

PMID35911971
PMCPMC9335355
OpenAlexW4285589784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.